Industry participates in the work of the Alliance through the Industry Forum, the venue for industry members to provide advice and recommendations to the Alliance Scientific Steering Committee and contribute financial support towards the ongoing research initiatives of the Alliance.
Co-Chairs
Florian von Raison, Clinical Development Head Neuroscience, Global Drug Development, Novartis, (FR)
Paola Zaratin, Director of Scientific Research, AISM — Italian MS Society, (IT)
Members
Bruce Bebo, Executive Vice President of Research, National MS Society (US)
Guy Buckle, Medical Director, Clinical Development, Biogen (US)
Licinio Craveiro, Neurologist, Senior Global Medical Director, Genentech Roche, (CH)
Kate Daniels, Director, International Progressive MS Alliance, (US)
Shawna Golden, Vice President, Global Initiatives, International Progressive MS Alliance, (US)
Jerome Hanna, Senior Medical Director, Clinical Development, Biogen, (UK)
Andreas Muehler, Chief Medical Officer, Immunic Therapeutics, (DE)
Ashish Pradhan, Executive Director Neuroimmunology, Disease Area Lead – Medical Affairs, Genentech, (US)
Nikolaos Sfikas, Senior IIS Global Group Head, Novartis, (FR)
Sana Syed, Senior Medical Director, Clinical Lead, Sanofi, (US)
Erik Wallström, Therapeutic Area Head, Neurology, Sanofi, (US)